Simpson Thacher is representing affiliates of KKR in connection with the recommended public offer to the shareholders of Biotage AB (“Biotage”) to tender all ordinary shares in Biotage (the “Offer”). The ordinary shares in Biotage are listed on Nasdaq Stockholm, Large Cap. The Offer values Biotage at approximately SEK 11,607 million. The completion of the Offer is conditional upon, inter alia, receipt of regulatory clearances.
Biotage is a leading provider of innovative and sustainable solutions for drug discovery, development, and analytical testing. Headquartered in Sweden, Biotage operates globally, serving over 80 countries.
The Simpson Thacher team includes Clare Gaskell, Emily Fanning, Isabel Lam, Simone Chua and Ally McCourt (M&A); Nicholas J. Shaw and Ziang Zhou (Corporate); Jonathan Lindabury and Nathan B. Utterback (Corporate – U.S.); Étienne Renaudeau, Pauline Patat, Luke Cowdell and Julia Kingwill (Antitrust); Meredith Jones and Mitchell Li (Tax).